Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 724.53M P/E - EPS this Y 81.70% Ern Qtrly Grth 179.90%
Income -294.33M Forward P/E -4.69 EPS next Y 72.70% 50D Avg Chg 7.00%
Sales 987.67M PEG -0.33 EPS past 5Y - 200D Avg Chg -23.00%
Dividend N/A Price/Book N/A EPS next 5Y 37.90% 52W High Chg -87.00%
Recommedations 2.50 Quick Ratio 0.93 Shares Outstanding 160.09M 52W Low Chg 50.00%
Insider Own 4.38% ROA -10.21% Shares Float 143.46M Beta 2.04
Inst Own 53.74% ROE - Shares Shorted/Prior 33.53M/30.50M Price 8.40
Gross Margin 16.18% Profit Margin -29.80% Avg. Volume 6,289,924 Target Price 20.00
Oper. Margin 39.01% Earnings Date Nov 7 Volume 6,171,024 Change -4.06%
About Novavax, Inc.

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Novavax, Inc. News
11/21/24 Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell?
11/21/24 Matt Gaetz Withdraws. Why That Might Be Bad News for RFK.
11/18/24 Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
11/15/24 Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHS
11/15/24 Update: Moderna, Novavax, Pfizer Shares Fall on Nomination of Anti-Vaxxer as US Health Secretary
11/15/24 Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick
11/15/24 Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
11/15/24 Trending tickers: Tesla, Alibaba, Pfizer, Domino's and Disney
11/15/24 Novavax, Inc. (NASDAQ:NVAX) Just Reported Earnings, And Analysts Cut Their Target Price
11/15/24 Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna and Novavax Stocks Slide.
11/15/24 Where are they now? 4 biotechs that soared then crashed during the pandemic
11/14/24 Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official
11/14/24 Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data
11/14/24 Novavax Third Quarter 2024 Earnings: Beats Expectations
11/13/24 Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut
11/13/24 Novavax to Participate in Jefferies London Healthcare Conference
11/13/24 Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial ...
11/12/24 Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals
11/12/24 FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine
11/12/24 Novavax Stock is Slipping After the Vaccine Maker Cut its Outlook Again
NVAX Chatroom

User Image Lazarus2024 Posted - 13 minutes ago

$NVAX Changes…pack your bags Marks! https://www.aol.com/trump-names-picks-fda-cdc-022029010.html

User Image ChannelGuru Posted - 2 hours ago

$NVAX it'll be interesting to see whether it's the fundamentals or technicals that will drive the moves in the weeks ahead.

User Image ChannelGuru Posted - 2 hours ago

$NVAX Sanofi watching from sidelines, looking at matrix m potentially being farmed out to competitors on long-term agreements. Can't be happy about this outcome. An agreement with CSL Sequiris would be alarming..

User Image ChannelGuru Posted - 3 hours ago

$NVAX So what's the realistic next step here.. funding from Barda?

User Image ChannelGuru Posted - 3 hours ago

$NVAX Next contemplated Master Transfer Agreement for Egg derived inactivated influenza vaccine. Likely target : CSL Sequiris

User Image ChannelGuru Posted - 4 hours ago

$NVAX The Master transfer agreement likely forsees a trigger or event (results of testing) that then makes the agreement binding. Scope locked and loaded : exclusive use of matrix M for bacterial pathogen applications Likely Purchaser : GSK (leader in bacterial using protein tech) Likely Master Transfer Agreement scope A master transfer agreement is a legal contract between two companies where the ownership of one company's product for use in certain scope is transferred to the other. This contract states who the selling and buying parties are, when the transfer is to take place (including event), and what compensation has been agreed upon to facilitate the transfer.

User Image ManiacalSlug Posted - 4 hours ago

$NVAX

User Image Ochaye Posted - 4 hours ago

$NVAX This whole interview is great but if you only have a minute, go to 48 secs and listen to them talk about Peter Marks. Seems he has a reputation: https://rumble.com/v5roz72-fda-approves-bird-flu-self-amplifying-mrna-trial-w-dr.-clare-craig-and-dr-j.html

User Image e0fknu2k Posted - 4 hours ago

$NVAX The whole world followed Bourla cult...

User Image JB9696 Posted - 4 hours ago

$NVAX here's an opinion piece Marty wrote https://nypost.com/2023/09/14/the-real-data-behind-the-new-covid-vaccines-the-white-house-is-pushing/

User Image jalal81 Posted - 4 hours ago

$NVAX Trump picks Dr. Marty Makary, a Johns Hopkins surgeon, for FDA chief. He’s a hardcore Novavax and( OCGN Covaxin)

User Image Bubuv Posted - 4 hours ago

$NVAX Dr Marty Makary is nominated to be the next FDA commissioner. I found his Twitter post about Novavax from 2021.

User Image DrSammy Posted - 4 hours ago

$NVAX

User Image BTC321 Posted - 4 hours ago

$NVAX https://x.com/sharonburnabybc/status/1859799586216477066?s=46&t=X6qO3UejysWvD0UxMTsJrA

User Image Quantmmm Posted - 4 hours ago

$NVAX the Surgeon General pick wasn't as good as hoped, CDC is better.

User Image JB9696 Posted - 4 hours ago

$NVAX oh the rats trying to flee the sinking ship. Offit now changing his tune on the recommendations he made. https://x.com/thechiefnerd/status/1859951739463516330?s=46&t=BPce-qeJbdLoEJcNYw2cKw

User Image DrSammy Posted - 4 hours ago

$NVAX 😁

User Image JB9696 Posted - 5 hours ago

$NVAX Peter marks quotes that will live in infamy. "I always choose the milk with the freshest date". "We are paying an incredibly high price for mRNA vaccines"

User Image BTC321 Posted - 5 hours ago

$NVAX https://x.com/outbreakupdates/status/1860109131035869597?s=46&t=X6qO3UejysWvD0UxMTsJrA

User Image Flowdollas Posted - 5 hours ago

$NVAX . In this study, we characterize recombinant A(H5N1) A/American Wigeon/South Carolina/22/000345-001/2021 (A/AW/SC/2021) clade 2.3.4.4b vaccine. Purified recombinant A/AW/SC/2021 HA trimers upon formulation with Matrix-M™ adjuvant, saponin-cholesterol-phospholipid icosahedral particles, non-covalently anchored to the vertices of the Matrix-M forming A(H5N1) HA–Matrix-M nanoparticles (H5-MNPs). In naive mice, two intranasal (IN) or intramuscular (IM) doses of A/AW/SC/2021 H5-MNP vaccine induced robust antibody- and cell-mediated immune responses, including neutralizing antibodies against A(H5N1). In non-human primates (NHPs) primed with seasonal influenza vaccine. 👑💪🏽🌎 https://www.biorxiv.org/content/10.1101/2024.11.21.624712v1

User Image stockflippper Posted - 5 hours ago

$NVAX

User Image JB9696 Posted - 5 hours ago

$NVAX pack you bags Pete you pos https://x.com/marionawfal/status/1860128251324019098?s=46&t=BPce-qeJbdLoEJcNYw2cKw

User Image LRdefender97 Posted - 5 hours ago

$NVAX https://www.reuters.com/world/us/trump-names-dave-weldon-his-pick-direct-cdc-2024-11-23/

User Image Jeffmeister2005 Posted - 6 hours ago

$NVAX Infect them ALL..... & LET NVAX CURE THEM ALL

User Image Jeffmeister2005 Posted - 6 hours ago

$NVAX $10 / this year would be fantastic.... 5 weeks until 2025 $20+ /next year would be beautiful 😍 🤩 👌 ❣️ B U L L I S H

User Image Songoku9 Posted - 7 hours ago

$NVAX @framus_morrigan your thoughts? Seems like a solid reversal to me. Would not be surprised to see 12$ or more again this year.

User Image Chelsea100 Posted - 7 hours ago

$NVAX huge!!!! https://x.com/doneford/status/1860109829815054608?s=46&t=lkQ3_6pbI_wwJJuBKrPrMw

User Image BTC321 Posted - 7 hours ago

$nvax to be honest - every 2nd person - or even more wear masks! i mean the japanese people only. they‘re such nice and friendly people. i love it!

User Image BTC321 Posted - 7 hours ago

$NVAX this is absolutly huge! https://www.biorxiv.org/content/10.1101/2024.11.21.624712v1 japan already holds an emergency conference! https://www.nippon.com/en/news/yjj2024112100890/

User Image SeekingNova Posted - 7 hours ago

$NVAX I had a busy day today and tried to publish a post during a break, and it was up for less than a second and then it disappeared. I hope this board is not manipulated 😅. Here is my post: Volume is below average. So the gain we are seeing today is most likely due to sector growth. Before Christmas we still have two catalysts: 1. Nova’s own flu and CIC back on track; and 2. Sanofi initiates phase 1/2 of its CIC that incorporates Nova’s COVID. How big will the Christmas gift be? 🎁 🎅 🎄 Pretty benign post, right? Why was it taken down/not published?

Analyst Ratings
B. Riley Securities Buy Aug 12, 24
JP Morgan Underweight Aug 12, 24
B. Riley Securities Buy Aug 2, 24
JP Morgan Underweight Jul 30, 24
B of A Securities Neutral Jun 14, 24
B. Riley Securities Buy May 23, 24
TD Cowen Hold May 13, 24
HC Wainwright & Co. Buy May 13, 24
B of A Securities Neutral May 10, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Dubovsky Filip President, R&D President, R&D Dec 14 Option 5.69 2,833 16,120 55,150 12/18/23
Dubovsky Filip President, R&D President, R&D Nov 05 Option 7.06 1,400 9,884 52,994 11/07/23
Dubovsky Filip President, R&D President, R&D Sep 16 Option 7.71 12,644 97,485 57,702 09/19/23
Trizzino John EVP, CCO and CBO EVP, CCO and CBO Mar 10 Option 6.52 4,609 30,051 11,531 03/14/23
Kelly James Patrick EVP, CFO and Treasur.. EVP, CFO and Treasurer Mar 10 Option 6.52 4,609 30,051 5,832 03/14/23
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Mar 10 Option 6.52 4,609 30,051 13,058 03/14/23
Glenn Gregory M President, R&D President, R&D Mar 06 Buy 7.01 6,000 42,060 14,473 03/14/23
Glenn Gregory M President, R&D President, R&D Mar 06 Option 6.52 6,298 41,063 20,771 03/14/23
YOUNG JAMES F Director Director Mar 31 Sell 74.21 12,500 927,625 62,590 04/04/22
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Dec 01 Sell 197.3 5,000 986,500 2,760 12/03/21
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Dec 01 Option 19.08 5,000 95,400 7,760 12/03/21
Glenn Gregory M President, R&D President, R&D Nov 23 Option 19.08 8,250 157,410 12,311 11/24/21
Glenn Gregory M President, R&D President, R&D Nov 23 Sell 200.02 8,250 1,650,165 4,061 11/24/21
Glenn Gregory M President, R&D President, R&D Nov 02 Option 19.08 8,250 157,410 12,311 11/04/21
Glenn Gregory M President, R&D President, R&D Nov 02 Sell 186.83 8,250 1,541,348 4,061 11/04/21
Glenn Gregory M President, R&D President, R&D Oct 26 Option 10.33 11,712 120,985 5,439 10/28/21
Glenn Gregory M President, R&D President, R&D Oct 26 Sell 132.97 10,334 1,374,112 4,061 10/28/21
Glenn Gregory M President, R&D President, R&D Oct 19 Option 19.08 8,250 157,410 12,311 10/21/21
Glenn Gregory M President, R&D President, R&D Oct 19 Sell 166.54 8,250 1,373,955 4,061 10/21/21
Glenn Gregory M President, R&D President, R&D Oct 12 Option 19.08 8,250 157,410 12,311 10/14/21
Glenn Gregory M President, R&D President, R&D Oct 12 Sell 164.07 8,250 1,353,578 4,061 10/14/21
Glenn Gregory M President, R&D President, R&D Jun 17 Option 22.5 10,535 237,038 7,630 06/17/21
Glenn Gregory M President, R&D President, R&D Jun 17 Sell 191.31 8,127 1,554,776 2,811 06/17/21
Glenn Gregory M President, R&D President, R&D Apr 19 Option 61.73 10,531 650,079 7,630 04/19/21
MCMANUS MICHAEL A JR Director Director Mar 23 Sell 220.99 4,000 883,960 5,951 03/23/21
Trizzino John EVP, Chief Commercia.. EVP, Chief Commercial Officer Mar 09 Option 21.38 3,404 72,778 670 03/09/21
Trizzino John EVP, Chief Commercia.. EVP, Chief Commercial Officer Mar 09 Sell 163.31 3,211 524,388 287 03/09/21
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Feb 03 Option 26.71 15,022 401,238 15,297 02/03/21
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Feb 03 Sell 241.28 15,022 3,624,508 275 02/03/21
Trizzino John EVP, CMO and CBO EVP, CMO and CBO Jan 07 Option 23.25 13,756 319,827 1,436 01/07/21
Trizzino John EVP, CMO and CBO EVP, CMO and CBO Jan 07 Sell 114.35 17,913 2,048,352 287 01/07/21
Erck Stanley C President and CEO President and CEO Nov 18 Sell 90.33 52,316 4,725,704 20,495 11/18/20
Erck Stanley C President and CEO President and CEO Nov 18 Option 32.7 52,317 1,710,766 72,811 11/18/20
Trizzino John EVP, CBO and CFO EVP, CBO and CFO Oct 01 Sell 111.32 2,250 250,470 5,087 10/01/20
Erck Stanley C President and CEO President and CEO Oct 01 Sell 111.71 12,233 1,366,548 20,494 10/01/20
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Sep 30 Option 5.95 24,750 147,262 43,054 09/30/20
Herrmann John A III EVP, Chief Legal Off.. EVP, Chief Legal Officer Sep 30 Sell 110.91 42,779 4,744,618 275 09/30/20
Glenn Gregory M President, R&D President, R&D Sep 30 Option 5.95 25,000 148,750 46,510 09/30/20
Glenn Gregory M President, R&D President, R&D Sep 30 Sell 110.91 44,949 4,985,295 1,561 09/30/20
Trizzino John EVP, CBO and CFO EVP, CBO and CFO Sep 30 Option 5.95 29,600 176,120 53,008 09/30/20
Trizzino John EVP, CBO and CFO EVP, CBO and CFO Sep 30 Sell 110.86 43,321 4,802,567 7,337 09/30/20
Erck Stanley C President and CEO President and CEO Sep 30 Option 5.95 50,000 297,500 74,606 09/30/20
Erck Stanley C President and CEO President and CEO Sep 30 Sell 110.91 29,112 3,228,813 32,727 09/30/20